Call participants
- Chief Executive Officer — Chad R. Abraham
- President — Debbra Lynn Schoneman
- Chief Financial Officer — Katherine Patricia Clune
Need a quote from a Motley Fool analyst? Email [email protected]
Takeaways
- Adjusted net revenues — $455 million, up 29% compared to the year-ago quarter on a non-GAAP basis, primarily driven by strong execution across all business lines in improved market conditions.
- Operating Margin — 21.2% for the quarter, above the company’s stated target and prior year levels.
- Adjusted diluted EPS — $3.82, exceeding the figure from the comparable period last year on a non-GAAP basis.
- Corporate Investment Banking Revenues — $292 million, representing significant year-over-year growth and marking one of the strongest third-quarter performances historically for this segment.
- Advisory Revenues — $212 million, up 13%, with 82 transactions completed; the financial services group led sector performance, supported by a resurgence in bank M&A activity.
- Bank M&A Market Position — Piper Sandler advised on six of the ten largest U.S. bank mergers closed in the quarter, ranking as the top U.S. M&A advisor to banks by announced transactions year to date.
- Debt Capital Markets Advisory — Third consecutive record year on pace, driven by higher average fees and a broader, more diversified client base.
- Corporate Financing Revenues — $80 million, the highest quarterly result since 2021; 38 financings completed, raising $14 billion in capital.
- Healthcare Equity Deals — Piper Sandler served as bookrunner on all 13 equity deals for healthcare clients this quarter.
- Managing Director Headcount — 183 investment banking Managing Directors at quarter-end, with eight new MDs added this year, including through the G-Squared acquisition and new hires in technology-related practices.
- Public Finance Revenues — $39 million from municipal financings, up 8%, supported by elevated issuance and broad-based activity across geographies and specialties.
- Municipal Transactions — 133 negotiated municipal deals executed, raising $6 billion of par for clients.
- Equity Brokerage Revenues — $54 million, down 7% sequentially from Q2 2025 as volatility moderated, but year-to-date revenues rose 8% compared to 2024.
- Fixed Income Revenues — $56 million, up 15%, with activity supported by anticipation of further interest rate cuts and balance sheet repositioning tied to M&A.
- Year-to-Date Net Revenues — $1.2 billion, an increase of 19%, with operating income of $238 million and operating margin of 19.2%.
- Compensation Ratio — 61.7% for the quarter and 62% for the first nine months, both improved compared to 2024 due to increased revenues.
- Non-Compensation Expenses — $65 million for the quarter (excluding reimbursed deal costs), up 6% year-over-year mainly from higher occupancy associated with headquarters relocation.
- Income Tax Rate — 28.8% for the quarter; year-to-date rate of 18.2% benefited from $27 million of restricted stock award vesting tax benefits, resulting in an underlying rate of 29.6% when excluded.
- Shareholder Returns — $16 million returned in the quarter, $204 million year-to-date through share repurchases and $5 per share in quarterly and special cash dividends.
- Dividend Announcement — Board approved a quarterly dividend of $0.70 per share, payable December 12 to shareholders of record as of November 25.
- Outlook: Advisory Revenue — Management expects fourth quarter advisory revenues to be similar to last year’s fourth quarter.
- Outlook: Corporate Financing Revenue — Management anticipates Q4 revenues to moderate from the particularly strong third quarter.
- Public Finance Outlook — Pipeline remains strong, with Q4 revenues expected to be similar to the third quarter.
Summary
Piper Sandler (PIPR 2.40%) reported its eighth consecutive quarter of year-over-year growth, citing improved market conditions and diversified business strength. Management highlighted market share gains in financial services and healthcare advisory, including leadership positions in U.S. bank M&A deals and major biopharma capital raises. Significant expansion efforts continued, with increased hiring in the technology group and integration of newly acquired G-Squared, positioning the firm for further growth in government services and defense technology. The call detailed continued growth in debt capital markets advisory and a robust pipeline in both advisory and public finance segments. Executive commentary pointed to resilient performance in equity and fixed income businesses despite sequential slowdowns, while forward guidance signaled expectations for strength in advisory activity and seasonally moderating financing revenues through year-end.
- CEO Abraham said, “We have now achieved eight consecutive quarters of year-over-year growth, underscoring our consistent execution and sustained momentum.”
- Public finance revenues increased 31% for the first nine months of 2025, significantly outpacing the 12% market issuance growth in par value over the same period.
- President Schoneman stated that refinancing in municipal markets due to lower rates “is likely more of a 2026 phenomenon than a 2025” as clients wait for further policy clarity.
- CFO Clune explained the underlying compensation ratio improvement results from managing retention and investing strategically as revenues rise.
- Management cited enhanced activity and expanded average deal sizes in agented debt and private capital advisory, partially offsetting limitations in consumer-facing sectors.
Industry glossary
- Agented Debt: Debt placements where an investment bank acts as an agent between issuers and capital providers, arranging and negotiating the terms but not necessarily underwriting the risk.
- Balance Sheet Restructuring: Financial advisory service provided during mergers or changing economic conditions, assisting clients—primarily banks—in optimizing asset and liability mix to improve financial resilience.
- Bookrunner: The lead underwriter of a securities issuance responsible for organizing the syndicate, selling the offering, and allocating shares to investors.
- G-Squared: Acquisition target specializing in government services and defense technology investment banking; now part of Piper Sandler’s technology group.
- Managing Director (MD): Senior executive in investment banking, typically responsible for leading client relationships, deal origination, and team management.
- Private Capital Advisory: A business unit advising institutional and private equity clients on secondary sales, fund structuring, and capital solutions in private markets.
- Special Districts: Niche area within municipal finance involving local government entities created for specific functions, such as infrastructure funding or service delivery.
Full Conference Call Transcript
Chad R. Abraham: Thank you, Kate. Good morning, everyone. Thank you for joining our third quarter 2025 earnings call. The market environment improved significantly in the third quarter. Equity markets reached record highs, and with lower volatility, equity underwriting meaningfully improved. Investor sentiment was helped by a calmer outlook on trade tensions and easing of monetary policy. Against this backdrop, we performed well with quarterly adjusted net revenues of $455 million, a 21.2% operating margin, and adjusted EPS of $3.82, all higher compared to the same period last year. Our strategy, anchored in deep sector expertise, market leadership, and a comprehensive suite of products across the client lifecycle, continues to resonate with clients.
We have now achieved eight consecutive quarters of year-over-year growth, underscoring our consistent execution and sustained momentum. This progress is supported by our investments in the business, the diversification of our platform, and an improving market backdrop.
During the third quarter, we generated $292 million in corporate investment banking revenues, reflecting significant growth over the prior year, and delivered one of our strongest third quarter performances on record. Our leading financial services and healthcare franchises each generated strong advisory and corporate financing revenues during the quarter. While both franchises have been perennial market leaders, we continue to expand these industry teams with additional subsector capabilities, product expertise, and connectivity with private equity clients. Our healthcare and financial services investment banking groups are among the largest teams in these sectors, led by senior bankers who have long tenures at Piper Sandler, a testament to our commitment to internal development and continuity.
Additionally, we continue to advise on some of the most significant transactions in these sectors. We advised on the largest U.S. bank M&A deal that has closed in 2025 and served as bookrunner for one of the largest biopharma capital raises in the market. As the outlook improves in both healthcare and financial services, we are well positioned to support our clients and deliver strong results for our shareholders. Specific to the advisory component of corporate investment banking, revenues for the quarter were $212 million, up 13% year-over-year as we completed 82 transactions. Sector performance was led by our financial services group.
See More

